Genomic Technology Capital Fund Lp Applied, 10% Owner at BG Medicine, Inc. (BGMD), bought 2,365,735 shares at $7.00 ($2.0M) on 2011-02-09, disclosed to the SEC on 2011-02-11.
Open-market purchase of $2.0M BGMD by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,079,975 | $0 | 0.0% |
| 2 | $7.00 | 3 | $21 | 0.0% |
| 3 | $7.00 | 43 | $301 | 0.0% |
| 4 | $7.00 | 14,285 | $100K | 5.0% |
| 5 | $7.00 | 271,429 | $1.9M | 95.0% |
| Total | $0.85 avg | 2,365,735 |
| $2.0M |
| 100% |